Church & Dwight has struck a deal to buy the Touchland hand-sanitizer brand for up to $880 million. Church & Dwight on Monday said the deal includes $700 million in cash and restricted stock at closing, along with a contingent payment of up to $180 million tied to Touchland’s sales this year. Church & Dwight, the Ewing, N.J., maker of Arm & Hammer and OxiClean products, said Touchland generated sales of about $130 million and earnings before interest, taxes, depreciation and amortization of roughly $55 million for the 12 months ended March 31, adding that the brand is expected to post double-digit sales growth this year and next. Continue Reading View Comments
Church & Dwight to Buy Touchland Hand-Sanitizer Brand
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...